Cuba's Promising Approach to Cancer
APRIL 6, 2020
by CESAR CHELALA
In 1991, I headed a United Nations Development Programme (UNDP) mission of Latin American physicians to evaluate a national Cuban project involving the use of interferon to treat inoperable lung cancer. At the time, there was a rumor that Fidel Castro had lung cancer and had a particular interest in the research about it. Castro showed his interest, in part, when he came to visit us and discussed the findings. At the time, interferon didnt seem to have a significant effect, but Cuban doctors have now developed a new treatment for lung cancer that offers promising results.
In September of 2011, the Chinese press agency Xinhua reported that Cuban doctors had produced the first therapeutic vaccine for lung cancer called CIMAvax-EGF. It was the result of a 25-year research project at Havanas Center for Molecular Immunology. Although the vaccine doesnt prevent lung cancer from developing in new patients, it turns later-stage lung cancer, specifically non-small-cell lung carcinoma (NSCLC) into a controllable chronic disease.
The vaccine contains a protein called epidermal growth factor (EGF). This substance stimulates the growth of cells and causes the tumors to multiply and grow uncontrollably. The vaccine contains EGF and a protein from the meningitis bacteria which enter into the bloodstream of patients and encourage their immune system to produce antibodies that suppress the effects of EGF.
As a result, the vaccine doesnt eliminate the tumors but prevents them from growing and spreading to other parts of the body. The vaccine is given to people who already have lung cancer and where the traditional treatments have proven to be ineffective. For these types of patients, the vaccine could be a life saver.
More:
https://www.counterpunch.org/2020/04/06/cubas-promising-approach-to-cancer/